Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation

Background Cytomegalovirus (CMV) reactivation after unmanipulated haploidentical stem cell transplantation (SCT) frequently occurs, causing life-threatening morbidities and transplantation failure. Pre-emptive therapy upon the detection of CMV viremia using antiviral agents is currently the standard...

Full description

Bibliographic Details
Main Authors:	Yu Wang, Lu Wang, Chao Ma, Peng Chen, Ning Lu, Jishan Du, Jiaojun Sun, Xu Qilong, Liping Dou, Dai-Hong Liu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-01-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/12/1/e007735.full

Similar Items

CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
by: Xiao-Hua Luo, et al.
Published: (2021-10-01)

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
by: Dolores Grosso, et al.
Published: (2019-09-01)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
by: Pei Xuying, et al.
Published: (2023-08-01)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
by: Zhenli Huang, et al.
Published: (2022-11-01)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
by: Melissa Panesso, et al.
Published: (2023-07-01)

CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey
by: Sevil Celilova, et al.
Published: (2020-02-01)

Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
by: Xing-Xing Yu, et al.
Published: (2022-02-01)

How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
by: Mohammad Vaezi, et al.
Published: (2016-10-01)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
by: Ping Zhang, et al.
Published: (2019-08-01)

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
by: Isabelle P. Lodding, MD, et al.
Published: (2018-06-01)

Combined Analysis of Early CD4<sup>+</sup> T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
by: Saskia Leserer, et al.
Published: (2021-11-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
by: Thomas Widmann, et al.
Published: (2008-01-01)

Review of Haploidentical Hematopoietic Cell Transplantation
by: Mehreen A. Khan, et al.
Published: (2018-12-01)

Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant
by: Taeeun Kim, et al.
Published: (2020-03-01)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.
by: Maximilian C Aichelburg, et al.
Published: (2015-01-01)

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse
by: Xiao-Hua Luo, et al.
Published: (2023-02-01)

M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation
by: Prashanth K Kandalla, et al.
Published: (2023-11-01)

P1334: THE IMPACT OF IMMUNOSUPPRESSION ON RECONSTITUTION OF CMV-SPECIFIC T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: A. Dmitrova, et al.
Published: (2022-06-01)

CMV genotyping using different samples in post renal transplant recipients with CMV disease
by: Ramya Barani, et al.
Published: (2017-10-01)

Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
by: Euri Seo, et al.
Published: (2021-01-01)

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
by: Nicolle H. R. Litjens, et al.
Published: (2017-09-01)

Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse
by: Xiao-Hua Luo, et al.
Published: (2023-05-01)

Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
by: Estéfani García-Ríos, et al.
Published: (2021-04-01)

Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects
by: Abana, CO, et al.
Published: (2017)

Correction: Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients.
by: Euri Seo, et al.
Published: (2023-01-01)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
by: Barbara Couturaud, et al.
Published: (2023-11-01)

Major TCR repertoire perturbation by immunodominant HLA-B*44:03-restricted CMV-specific T cells
by: Attaf, M, et al.
Published: (2018)

Circulating gluten‐specific, but not CMV‐specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire
by: Laura Cook, et al.
Published: (2020-01-01)

Major TCR Repertoire Perturbation by Immunodominant HLA-B*44:03-Restricted CMV-Specific T Cells
by: Meriem Attaf, et al.
Published: (2018-11-01)

Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience
by: Zhivka Stoykova, et al.
Published: (2024-12-01)

Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
by: Sarah E. Jackson, et al.
Published: (2017-06-01)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
by: Helen M McGuire, et al.
Published: (2020-01-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
by: Jong Man Kim, et al.
Published: (2015-01-01)

Impact of CMV Infection on Natural Killer Cell Clonal Repertoire in CMV-Naïve Rhesus Macaques
by: Lauren L. Truitt, et al.
Published: (2019-10-01)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
by: Alonso Corona, et al.
Published: (2009-08-01)

Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation
by: Ki Hyun Park, et al.
Published: (2020-05-01)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
by: Monica Miele, et al.
Published: (2021-03-01)